CEACAM5 Antikörper
(1 reference)-
- Target Alle CEACAM5 Antikörper anzeigen
- CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CEACAM5 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoprecipitation (IP)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- CB30
- Isotyp
- IgG1
- Top Product
- Discover our top product CEACAM5 Primärantikörper
-
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibody
CEACAM5 Reaktivität: Human WB, IHC, IP Wirt: Maus Monoclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, IHC (p), IHC (fro), IP Wirt: Maus Monoclonal CB30 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (AA 50-77), (N-Term) antibodyCEACAM5 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB18886 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (AA 35-165) antibodyCEACAM5 Reaktivität: Human FACS, ELISA Wirt: Maus Monoclonal 3B9C9 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, IF, IHC (f) Wirt: Maus Monoclonal CEA31 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, WB, ELISA, IHC (fro), cELISA Wirt: Maus Monoclonal 26-3-13 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) (AA 1-255) antibodyCEACAM5 Reaktivität: Human IF, WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human IHC, ELISA Wirt: Maus Monoclonal unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human FACS, IF, IHC (f), WB Wirt: Maus Monoclonal COL-1 unconjugated
anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) antibodyCEACAM5 Reaktivität: Human IF, WB, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle." in: Journal of immunological methods, Vol. 275, Issue 1-2, pp. 99-112, (2003) (PubMed).
-
: "Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle." in: Journal of immunological methods, Vol. 275, Issue 1-2, pp. 99-112, (2003) (PubMed).
-
- Target
- CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
- Andere Bezeichnung
- CD66e (CEACAM5 Produkte)
- Hintergrund
- Synonyms: CEA
- Gen-ID
- 1048
- UniProt
- P06731
-
